Skip to main content
XPOF
NYSE Trade & Services

Fund 1 Lifts XPOF Swap Exposure to ~10% as $5 Puts Expire Unused

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Travel & Leisure Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$4.39
Mkt Cap
$216.203M
52W Low
$3.565
52W High
$9.25
52W Position info
23% above low
Off High info
53% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

XPOF sits 23% above its 52-week low of $3.565.

Summary

Fund 1 Investments' third 13D amendment shows total return swaps on 4.21M XPOF shares (~9.98%) alongside 4.17M shares held outright (9.9%), with its 2.5M short $5 puts expiring unexercised. The activist now has economic exposure to roughly a fifth of the company while staying under the 19.9% poison-pill trigger.


Key Events · Ownership and Investor Activity · XPOF

  • Swap Notional Grows to ~10%

    Cash-settled total return swaps now reference 4,213,826 notional shares, about 9.98% of the outstanding class, up from the 3.57M shares disclosed on 2026-10-07.

  • Physical Stake Held at 9.9%

    Fund 1 owns 4,170,610 shares outright with sole voting and dispositive power; no share transactions occurred since Amendment No. 2.

  • $5 Puts Expire Unexercised

    The 2,500,000 short cash-settled put options with a $5 strike expired unexercised on 2026-10-16, removing a potential obligation to buy additional shares.

  • Poison Pill Caps Voting Stake

    The swaps carry no voting or dispositive rights, keeping Fund 1's voting position at 9.9% — below the 19.9% trigger in the rights plan adopted 2026-10-13.


Analysis · XPOF · Trade & Services

Fund 1 Investments now holds 4,170,610 shares (9.9%) outright plus cash-settled total return swaps on 4,213,826 notional shares — roughly another 9.98% of the class. That gives it economic exposure to about a fifth of Xponential without the voting power that would trip the poison pill's 19.9% trigger. The 2.5M short $5 puts expiring unexercised on October 16 removes a potential obligation to buy more stock, but also confirms the fund did not add physical shares. Against a backdrop of a 13% Q2 revenue decline, slashed guidance and a material weakness disclosure, this is an activist building leverage ahead of a board fight, not a passive position.

How filings like this one have moved

In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XPOF was trading at $4.39 on NYSE in the Trade & Services sector, with a market capitalization of approximately $216.2M. The 52-week trading range was $3.57 to $9.25. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XPOF - Latest Insights

XPOF
Oct 13, 2026, 7:11 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.94
Real-time Price: $4.39 info
Change: -$0.550 (-11%) info
Market Cap: $216.203M info
XPOF
Oct 12, 2026, 9:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $4.94
Real-time Price: $4.39 info
Change: -$0.550 (-11%) info
Market Cap: $216.203M info
XPOF
Oct 07, 2026, 5:20 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.85
Real-time Price: $4.39 info
Change: -$0.460 (-9%) info
Market Cap: $216.203M info
XPOF
Sep 30, 2026, 8:45 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $4.50
Real-time Price: $4.39 info
Change: -$0.110 (-2%) info
Market Cap: $216.203M info
XPOF
Aug 25, 2026, 4:51 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $5.13
Real-time Price: $4.39 info
Change: -$0.740 (-14%) info
Market Cap: $216.203M info